Changzhou DSB Medical Co., Ltd. -mRNA Applications

About Careers Investors

Language
- 中文简体
- English
- Español
- 日本語
- عرب .

Markets

which specializes in R&D, manufacture and marketing of disposal medical products.

mRNA applications

In the field of mRNA, nebulization drug delivery technology is used to introduce mRNA into respiratory cells, guiding them to synthesize the required proteins and achieving the goal of treating respiratory diseases.

With the continuous development of biotechnology, the field of mRNA has become an important research direction in the pharmaceutical industry. MRNA, as a molecule that can guide protein synthesis, has broad application prospects. As a highly concerned drug delivery method in recent years, respiratory administration has the advantages of convenience, safety, and effectiveness, and has market application value in the field of mRNA.

In the field of mRNA, nebulization drug delivery technology is widely used to prevent and treat respiratory infectious diseases, respiratory diseases such as asthma, and pulmonary inflammation. In recent years, with the continuous advancement of new drug research and development, the mRNA vaccine and drug markets have shown a rapid growth trend. It is predicted that the global mRNA vaccine and drug market will continue to expand in the coming years. As one of the important delivery methods for mRNA therapy, nebulization will also increase its market demand.

The clinical application of respiratory administration in the mRNA field mainly includes the prevention and treatment of infectious diseases

Clinical application

In clinical applications, nebulization has shown significant advantages in the mRNA field.
Firstly, nebulized administration can directly target the respiratory tract and improve the efficacy of the drug.
Secondly, nebulization can reduce adverse reactions of drugs and improve patient compliance.
In addition, nebulization is easy to operate, convenient and fast, and suitable for fields such as home medicine and first aid.
However, atomization administration also has certain shortcomings, such as uneven distribution of drug particles, which require further improvement and improvement of atomization technology.
After years of research and development, DSB has solved industry technical problems through micro/nano chip processing technology and microfluidic processing technology, providing drug delivery devices and microfluidic chips for the mRNA field.

Improving efficacy

Good absorption and quick effect

Reduce adverse reactions

When nebulized administration, the drug only acts on local tissues and has fewer systemic adverse reactions, which can reduce the adverse reactions of the drug.

Simple and convenient operation

The atomization administration operation is simple and convenient, without the need for injection. Instead, the medication is inhaled into the body in a mist like form through the atomization device.

Application prospect

With the continuous development of biotechnology and the improvement of people's health awareness, the application prospects of respiratory administration in the field of mRNA will be even broader. In the coming years, with the development and launch of more new mRNA vaccines and therapeutic drugs, as well as the increasing demand for home healthcare and emergency care, the respiratory drug market will usher in a broader development space.

Provide green intelligent solutions for precision medicine and personalized life and health management